New AI model to boost patient response to cancer therapy
Australian researchers have developed a new artificial intelligence (AI) tool that can help to select the most suitable treatment for cancer patients.
Australian researchers have developed a new artificial intelligence (AI) tool that can help to select the most suitable treatment for cancer patients.
Developing nerve cells outside the brain is where neuroblastoma, a common childhood disease, starts.
An international team of researchers have identified how three novel genes cause neurodevelopmental disorders, particularly developmental delay, intellectual disability and autism.
Cell specialisation demonstrates the unity and diversity of biology.
The study, published in the journal Molecular Cancer Therapeutics, focused on breast cancer cells in mice.
Almost all the cellular reactions or processes are mediated by protein (or RNA) catalysts called enzymes
